Phosphodiesterase 4 inhibitors: a new class of agents for the treatment of chronic obstructive pulmonary disease
2020 ◽
Vol 35
(2)
◽
pp. 276-283
◽
2014 ◽
Vol 35
(1)
◽
pp. 203-217
◽